British Journal of Dermatology

Research snippets
pp. i-i(1)

Writing a British Association of Dermatologists clinical guideline: an update on the process and guidance for authors
pp. 725-728(4)
Authors: Bell, H.K.; Ormerod, A.D.

Contact sensitization to fragrances in the general population: a Koch's approach may reveal the burden of disease
pp. 729-735(7)
Authors: Thyssen, J.P.; Menné, T.; Linneberg, A.; Johansen, J.D.

Serum mast cell tryptase is not a useful marker for disease severity in psoriasis or atopic dermatitis
pp. 736-740(5)
Authors: Gerdes, S.; Kurrat, W.; Mrowietz, U.

Human immunodeficiency virus atropy induces modification of subcutaneous adipose tissue architecture: in vivo visualization by high-resolution magnetic resonance imaging
pp. 741-746(6)
Authors: Josse, G.; Gensanne, D.; Aquilina, C.; Bernard, J.; Saint-Martory, C.; Lagarde, J.M.; Schmitt, A.M.

CCL18 is expressed in patients with bullous pemphigoid and parallels disease course
pp. 747-755(9)
Authors: Günther, C.; Carballido-Perrig, N.; Kopp, T.; Carballido, J.M.; Pfeiffer, C.

Dermoscopy of cutaneous leishmaniasis
pp. 756-761(6)
Authors: Llambrich, A.; Zaballos, P.; Terrasa, F.; Torne, I.; Puig, S.; Malvehy, J.

Troglitazone suppresses transforming growth factor-β1-induced collagen type I expression in keloid fibroblasts
pp. 762-770(9)
Authors: Zhang, G-Y.; Yi, C-G.; Li, X.; Ma, B.; Li, Z-J.; Chen, X-L.; Guo, S-Z.; Gao, W-Y.

Ichthyosis vulgaris: novel FLG mutations in the German population and high presence of CD1a+ cells in the epidermis of the atopic subgroup
pp. 771-781(11)
Authors: Oji, V.; Seller, N.; Sandilands, A.; Gruber, R.; Gerß, J.; Hüffmeier, U.; Hamm, H.; Emmert, S.; Aufenvenne, K.; Metze, D.; Luger, T.; Loser, K.; Hausser, I.; Traupe, H.; McLean, W.H.I.

Immunological effects of stress in psoriasis
pp. 782-785(4)
Authors: Schmid-Ott, G.; Jaeger, B.; Boehm, T.; Langer, K.; Stephan, M.; Raap, U.; Werfel, T.

Negative predictive value of drug skin tests in investigating cutaneous adverse drug reactions
pp. 786-794(9)
Authors: Waton, J.; Tréchot, P.; Loss-Ayav, C.; Schmutz, J.L.; Barbaud, A.

Nerve blocks enable adequate pain relief during topical photodynamic therapy of field cancerization on the forehead and scalp
pp. 795-800(6)
Authors: Halldin, C.B.; Paoli, J.; Sandberg, C.; Gonzalez, H.; Wennberg, A.-M.

Rainbow pattern in Kaposi's sarcoma under polarized dermoscopy: a dermoscopic pathological study
pp. 801-809(9)
Authors: Cheng, S-T.; Ke, C-L.K.; Lee, C-H.; Wu, C-S.; Chen, G-S.; Hu, S.C-S.

Shrinkage of skin excision specimens: formalin fixation is not the culprit
pp. 810-814(5)
Authors: Dauendorffer, J.N.; Bastuji-Garin, S.; Guéro, S.; Brousse, N.; Fraitag, S.

Quality of life and psychological distress in patients with cutaneous lymphoma
pp. 815-822(8)
Authors: Sampogna, F.; Frontani, M.; Baliva, G.; Lombardo, G.A.; Alvetreti, G.; Di Pietro, C.; Tabolli, S.; Russo, G.; Abeni, D.

Chronic urticaria: do urticaria nonexperts implement treatment guidelines? A survey of adherence to published guidelines by nonexperts
pp. 823-827(5)
Authors: Ferrer, M.; Jáuregui, I.; Bartra, J.; Dávila, I.; del Cuvillo, A.; Montoro, J.; Mullol, J.; Valero, A.; Sastre, J.

Nickel allergy as risk factor for hand eczema: a population-based study
pp. 828-834(7)
Authors: Josefson, A.; Färm, G.; Magnuson, A.; Meding, B.

Comparison of patients with and without digital ulcers in systemic sclerosis: detection of possible risk factors
pp. 835-843(9)
Authors: Sunderkötter, C.; Herrgott, I.; Brückner, C.; Moinzadeh, P.; Pfeiffer, C.; Gerß, J.; Hunzelmann, N.; Böhm, M.; Krieg, T.; Müller-Ladner, U.; Genth, E.; Schulze-Lohoff, E.; Meurer, M.; Melchers, I.; Riemekasten, G.

Impact of neurofibromatosis 1 upon quality of life in childhood: a cross-sectional study of 79 cases
pp. 844-848(5)
Authors: Wolkenstein, P.; Rodriguez, D.; Ferkal, S.; Gravier, H.; Buret, V.; Algans, N.; Simeoni, M.-C.; Bastuji-Garin, S.

Induction of protoporphyrin IX by aminolaevulinic acid in actinic keratosis, psoriasis and normal skin: preferential porphyrin enrichment in differentiated cells
pp. 849-857(9)
Authors: Smits, T.; van Laarhoven, A.I.M.; Staassen, A.; van de Kerkhof, P.C.M.; van Erp, P.E.J.; Gerritsen, M.-J.P.

Efficacy and safety of tacrolimus ointment 0·1% vs. betamethasone 17-valerate 0·1% in the treatment of chronic paronychia: an unblinded randomized study
pp. 858-860(3)
Authors: Rigopoulos, D.; Gregoriou, S.; Belyayeva, E.; Larios, G.; Kontochristopoulos, G.; Katsambas, A.

Evaluation of safety and efficacy of topical prostaglandin E₂ in treatment of vitiligo
pp. 861-863(3)
Authors: Kapoor, R.; Phiske, M.M.; Jerajani, H.R.

Pilot study of dual-wavelength (532 and 633 nm) laser Doppler imaging and infrared thermography of morphoea
pp. 864-867(4)
Authors: Moore, T.L.; Vij, S.; Murray, A.K.; Bhushan, M.; Griffiths, C.E.M.; Herrick, A.L.

Acantholytic ectodermal dysplasia: clinicopathological study of a new desmosomal disorder
pp. 868-874(7)
Authors: Winik, B.C.; Asial, R.A.; McGrath, J.A.; South, A.P.; Boente, M.C.

The use of galeotomies to aid the closure of surgical defects on the forehead and scalp
pp. 875-877(3)
Authors: Barry, R.B.M.; Lawrence, C.M.; Langtry, J.A.A.

Compound heterozygosity for ARS component B mutations in a Dutch patient with mal de Meleda
pp. 878-880(3)
Authors: Nellen, R.G.L.; vanGeel, M.; Steijlen, P.M.; vanSteensel, M.A.M.

Novel CTSC mutations in a patient with Papillon-Lefèvre syndrome with recurrent pyoderma and minimal oral and palmoplantar involvement
pp. 881-883(3)
Authors: Castori, M.; Madonna, S.; Giannetti, L.; Floriddia, G.; Milioto, M.; Amato, S.; Castiglia, D.

Irreversible and severe alopecia following docetaxel or paclitaxel cytotoxic therapy for breast cancer
pp. 883-885(3)
Authors: Prevezas, C.; Matard, B.; Pinquier, L.; Reygagne, P.

Revisiting the past: utilizing archival tissue for the detection and quantification of gene expression
pp. 885-886(2)
Authors: Singh, S.; Kaye, S.; Francis, N.D.; Peston, D.; Gore, M.E.; McClure, M.O.; Bunker, C.B.

Multifocal primary cutaneous CD30+ anaplastic large cell lymphoma responsive to thalidomide: the molecular mechanism and the clinical application
pp. 887-889(3)
Authors: Lee, J-H.; Cheng, A-L.; Lin, C-W.; Kuo, S-H.

Subcutaneous panniculitis-like T-cell lymphoma in a patient receiving etanercept for rheumatoid arthritis
pp. 889-890(2)
Authors: Michot, C.; Costes, V.; Gerard-Dran, D.; Guillot, B.; Combes, B.; Dereure, O.

Hand, foot and mouth disease in a healthy adult caused by intrafamilial transmission of enterovirus 71
pp. 890-892(3)
Authors: Tai, W-C.; Hsieh, H-J.; Wu, M-T.

PlayStation palmar hidradenitis
pp. 892-894(3)
Authors: Kasraee, B.; Masouyé, I.; Piguet, V.

CD20+ primary cutaneous T-cell lymphoma presenting as a solitary extensive plaque
pp. 894-896(3)
Authors: Oshima, H.; Matsuzaki, Y.; Takeuchi, S.; Nakano, H.; Sawamura, D.

A case of natural killer cell monoclonal expansion during efalizumab treatment in a patient with psoriasis
pp. 896-897(2)
Authors: Caproni, M.; Volpi, W.; Chiarini, C.; Antiga, E.; Giomi, B.; Fabbri, P.

News and Notices
pp. 897-898(2)

British Society for Investigative Dermatology Annual Meeting
pp. 899-928(30)